We selected different series of amino acid conjugates depending on their different hydrophilic or hydrophobic behaviours beside their different aliphatic or aromatic nature hoping to achieve superior DHFR inhibition activity that exceed classical antifolates and to treat the classical antifolates resistant cancer cell lines. Here, DHFR is linked to cancer.